Description
Alectinib
Each capsule contains Alectinib HCl 161.33 mg equivalent to Alectinib. … 150mg.
INDICATION
LuciAle is a kinase inhibitor indicated for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) as detected by an FDA- approved test.
DOSAGE AND USE
600 mg orally twice daily. Administer LuciAle with food.
STORAGE
In a dry place and store at 20°C to 25°C.
MANUFACTURED AND MARKETED BY
LUCIUS PHARMACEUTICALS(LAO) CO., LTD No.26, Thongmang village, Xaythany district, Vientiane Capital, Laos
WARNING
Keep medicine out of reach of Children. Do not administer LuciAle during Pregnancy and Lactation.
Reviews
There are no reviews yet.